熱門資訊> 正文
Metagenomi报告FY结果
2024-03-27 22:59
- Metagenomi press release (NASDAQ:MGX): FY GAAP EPS of -$20.05
- Collaboration revenue of $44.76M (vs. $17.20M Y/Y)
More on Metagenomi, Inc.
- Stocks To Watch: Eyes On Broadcom, Target, Costco, Rivian And Small Caps
- Metagenomi Begins Genetic Treatment IPO Rollout
- Jefferies, BMO bullish on newly public Metagenomi
- Moderna-backed Metagenomi sees stock fall 31% after $94M IPO
- Historical earnings data for Metagenomi, Inc.
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。